"DNA Mutational Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Biochemical identification of mutational changes in a nucleotide sequence.
| Descriptor ID |
D004252
|
| MeSH Number(s) |
E05.393.760.700.300
|
| Concept/Terms |
DNA Mutational Analysis- DNA Mutational Analysis
- Analysis, DNA Mutational
- Analyses, DNA Mutational
- DNA Mutational Analyses
- Mutational Analyses, DNA
- Mutational Analysis, DNA
|
Below are MeSH descriptors whose meaning is more general than "DNA Mutational Analysis".
Below are MeSH descriptors whose meaning is more specific than "DNA Mutational Analysis".
This graph shows the total number of publications written about "DNA Mutational Analysis" by people in this website by year, and whether "DNA Mutational Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 12 | 12 |
| 1996 | 1 | 6 | 7 |
| 1997 | 1 | 3 | 4 |
| 1998 | 1 | 11 | 12 |
| 1999 | 1 | 11 | 12 |
| 2000 | 0 | 18 | 18 |
| 2001 | 1 | 18 | 19 |
| 2002 | 1 | 19 | 20 |
| 2003 | 3 | 18 | 21 |
| 2004 | 1 | 15 | 16 |
| 2005 | 3 | 29 | 32 |
| 2006 | 0 | 25 | 25 |
| 2007 | 2 | 14 | 16 |
| 2008 | 1 | 15 | 16 |
| 2009 | 2 | 23 | 25 |
| 2010 | 1 | 22 | 23 |
| 2011 | 0 | 17 | 17 |
| 2012 | 3 | 18 | 21 |
| 2013 | 1 | 16 | 17 |
| 2014 | 2 | 35 | 37 |
| 2015 | 5 | 24 | 29 |
| 2016 | 5 | 16 | 21 |
| 2017 | 1 | 15 | 16 |
| 2018 | 3 | 15 | 18 |
| 2019 | 1 | 11 | 12 |
| 2020 | 0 | 12 | 12 |
| 2021 | 0 | 14 | 14 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Mutational Analysis" by people in Profiles.
-
Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay. J Clin Endocrinol Metab. 2024 Aug 13; 109(9):2269-2273.
-
Computationally restoring the potency of a clinical antibody against Omicron. Nature. 2024 May; 629(8013):878-885.
-
Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases. Hum Pathol. 2024 06; 148:1-6.
-
TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present. Hum Pathol. 2024 04; 146:1-7.
-
T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases. Am J Clin Pathol. 2023 04 04; 159(4):325-336.
-
BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol. 2023 Mar; 50(3):223-229.
-
Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma. Am J Clin Pathol. 2022 08 04; 158(2):263-269.
-
Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer. Endocrine. 2022 05; 76(2):491-494.
-
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms. Am J Surg Pathol. 2021 12 01; 45(12):1597-1605.
-
Bi-allelic variants in OGDHL cause a neurodevelopmental spectrum disease featuring epilepsy, hearing loss, visual impairment, and ataxia. Am J Hum Genet. 2021 12 02; 108(12):2368-2384.